VRNA241220P00015000 Option on Verona Pharma PLC

VRNA Stock  USD 69.63  2.51  3.74%   
Verona Pharma's latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 0.8 with a put-to-call open interest ratio of 0.76 over 30 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on May 16th 2025. The total put volume is at 82.0, with calls trading at the volume of 168. This yields a 0.49 put-to-call volume ratio.

Open Interest Against May 16th 2025 Option Contracts

The chart above shows Verona Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Verona Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Verona Pharma's option, there is no secondary market available for investors to trade.

Verona Pharma Maximum Pain Price Across 2025-05-16 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Verona Pharma close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Verona Pharma's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Verona Pharma

Analyzing Verona Pharma's in-the-money options over time can help investors to take a profitable long position in Verona Pharma regardless of its overall volatility. This is especially true when Verona Pharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Verona Pharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Verona Pharma's stock while costing only a fraction of its price.
Verona Pharma's stock options are financial instruments that give investors the right to buy or sell shares of Verona Pharma PLC common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Verona stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Verona Pharma's stock price goes up or down, the stock options follow.
At present, Verona Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 498 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 524.4 M.

Verona Pharma PLC In The Money Call Balance

When Verona Pharma's strike price is surpassing the current stock price, the option contract against Verona Pharma PLC stock is said to be in the money. When it comes to buying Verona Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Verona Pharma PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Verona Current Options Market Mood

Verona Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Verona Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Verona Pharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Verona Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Verona contract

Base on the Rule 16, the options market is currently suggesting that Verona Pharma PLC will have an average daily up or down price movement of about 0.05% per day over the life of the 2025-05-16 option contract. With Verona Pharma trading at USD 69.63, that is roughly USD 0.0348. If you think that the market is fully incorporating Verona Pharma's daily price movement you should consider buying Verona Pharma PLC options at the current volatility level of 0.8%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Verona Pharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Verona calls. Remember, the seller must deliver Verona Pharma PLC stock to the call owner when a call is exercised.

Verona Pharma Option Chain

When Verona Pharma's strike price is surpassing the current stock price, the option contract against Verona Pharma PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Verona Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Verona. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Verona. It also shows strike prices and maturity days for a Verona Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
VRNA250516C00030000230.037.5 - 42.024.7In
Call
VRNA250516C000350004635.032.5 - 37.028.04In
Call
VRNA250516C000400005640.027.6 - 32.025.9In
Call
VRNA250516C0004500019845.023.1 - 26.924.0In
Call
VRNA250516C000500004650.018.5 - 21.521.5In
Call
VRNA250516C000550002455.014.1 - 18.515.73In
Call
VRNA250516C0006000018060.011.1 - 14.510.7In
Call
VRNA250516C0006500082765.08.0 - 10.39.2In
Call
VRNA250516C000700002470.06.2 - 9.36.9Out
Call
VRNA250516C000750008575.04.3 - 6.74.42Out
Call
VRNA250516C00080000242080.03.0 - 3.93.4Out
Call
VRNA250516C000850003385.00.65 - 4.72.35Out
Call
VRNA250516C00090000190.00.0 - 3.51.5Out
Call
VRNA250516C00095000195.00.0 - 2.951.75Out
Call
VRNA250516C001000002100.00.0 - 4.41.4Out
 Put
VRNA250516P00025000325.00.0 - 4.80.36Out
 Put
VRNA250516P00035000235.00.0 - 4.81.8Out
 Put
VRNA250516P0004000033540.00.0 - 4.80.8Out
 Put
VRNA250516P0004500084645.00.0 - 4.81.55Out
 Put
VRNA250516P0005000033850.00.5 - 2.22.57Out
 Put
VRNA250516P00055000104155.00.0 - 3.92.3Out
 Put
VRNA250516P0006000013460.01.9 - 4.13.6Out
 Put
VRNA250516P000650001165.02.35 - 6.05.0Out
 Put
VRNA250516P0007000030170.06.1 - 7.47.1In
 Put
VRNA250516P00075000075.08.0 - 12.08.0In
 Put
VRNA250516P00080000080.012.0 - 15.412.0In
 Put
VRNA250516P00085000085.015.8 - 19.415.8In
 Put
VRNA250516P00090000090.020.2 - 24.020.2In
 Put
VRNA250516P00095000095.024.1 - 28.424.1In
 Put
VRNA250516P001000000100.029.1 - 33.029.1In

Verona Pharma Market Cap Over Time

   Market Cap   
       Timeline  

Verona Total Stockholder Equity

Total Stockholder Equity

214.79 Million

At present, Verona Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Verona Pharma Corporate Management

Caroline DiazSenior AffairsProfile
LCSW BAG CounselProfile
Matthew CasbonMarketing SalesProfile
Peter SpargoSenior ControlsProfile
Kathleen MDChief OfficerProfile
B ASIAGeneral CounselProfile
When determining whether Verona Pharma PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verona Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verona Pharma Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verona Pharma Plc Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verona Pharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verona Pharma. If investors know Verona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verona Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Revenue Per Share
0.519
Return On Assets
(0.24)
Return On Equity
(0.76)
The market value of Verona Pharma PLC is measured differently than its book value, which is the value of Verona that is recorded on the company's balance sheet. Investors also form their own opinion of Verona Pharma's value that differs from its market value or its book value, called intrinsic value, which is Verona Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verona Pharma's market value can be influenced by many factors that don't directly affect Verona Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verona Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verona Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verona Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.